High throughput screen for the improvement of inducible promoters for tumor microenvironment cues

Cancer immunotherapies are highly potent and are gaining wide clinical usage. However, severe side effects require focusing effector immune cell activities on the tumor microenvironment (TME). We recently developed a chimeric antigen receptor tumor-induced vector (CARTIV), a synthetic promoter activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharabi, Omri, Greenshpan, Yariv, Ofir, Noa, Ottolenghi, Aner, Levi, Tamar, Olender, Leonid, Adler-Agmon, Zachor, Porgador, Angel, Gazit, Roi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065017/
https://www.ncbi.nlm.nih.gov/pubmed/35504918
http://dx.doi.org/10.1038/s41598-022-11021-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065017/
https://www.ncbi.nlm.nih.gov/pubmed/35504918
http://dx.doi.org/10.1038/s41598-022-11021-1

Ejemplares similares